Target type: biologicalprocess
Any process that modulates the frequency, rate or extent of voltage-gated calcium channel activity. [GOC:BHF, GOC:TermGenie]
Regulation of voltage-gated calcium channel activity is a complex and tightly controlled process crucial for a wide range of cellular functions, including neurotransmission, muscle contraction, hormone secretion, and gene expression. Calcium channels are transmembrane proteins that open in response to changes in membrane potential, allowing calcium ions to flow into the cell. This influx of calcium triggers a cascade of intracellular signaling events that ultimately lead to the desired cellular response.
The regulation of voltage-gated calcium channel activity involves multiple mechanisms, including:
1. **Voltage sensing:** The channel's voltage-sensing domain detects changes in membrane potential. When the membrane depolarizes, the voltage sensor shifts its conformation, causing the channel to open.
2. **Inactivation:** After opening, calcium channels undergo inactivation, a process that limits the duration of calcium influx. Inactivation is typically mediated by a specific domain within the channel, known as the inactivation gate.
3. **Modulation by intracellular signaling pathways:** Calcium channel activity can be modulated by a variety of intracellular signaling pathways. For example, protein kinases can phosphorylate calcium channels, altering their activity.
4. **Interaction with other proteins:** Calcium channels can interact with a variety of other proteins, including scaffolding proteins, auxiliary subunits, and signaling molecules. These interactions can influence channel localization, trafficking, and activity.
5. **Pharmacological regulation:** Calcium channels are targets of numerous pharmacological agents, including calcium channel blockers and activators. These drugs can be used to treat a variety of conditions, including hypertension, arrhythmias, and epilepsy.
The precise mechanisms of calcium channel regulation vary depending on the specific channel subtype and the cellular context. However, the overall goal is to ensure that calcium influx is tightly controlled, allowing for precise and efficient cellular signaling.
In summary, regulation of voltage-gated calcium channel activity is a complex and multifaceted process involving voltage sensing, inactivation, modulation by intracellular signaling pathways, interaction with other proteins, and pharmacological regulation. This fine-tuned control ensures proper calcium signaling and is essential for a wide range of physiological functions.'
"
Protein | Definition | Taxonomy |
---|---|---|
Voltage-dependent L-type calcium channel subunit beta-3 | A voltage-dependent L-type calcium channel subunit beta-3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P54284] | Homo sapiens (human) |
Voltage-dependent L-type calcium channel subunit beta-1 | A voltage-dependent L-type calcium channel subunit beta-1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q02641] | Homo sapiens (human) |
Voltage-dependent L-type calcium channel subunit beta-2 | A voltage-dependent L-type calcium channel subunit beta-2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q08289] | Homo sapiens (human) |
Voltage-dependent L-type calcium channel subunit beta-4 | A voltage-dependent L-type calcium channel subunit beta-4 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O00305] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
tacrine | tacrine : A member of the class of acridines that is 1,2,3,4-tetrahydroacridine substituted by an amino group at position 9. It is used in the treatment of Alzheimer's disease. Tacrine: A cholinesterase inhibitor that crosses the blood-brain barrier. Tacrine has been used to counter the effects of muscle relaxants, as a respiratory stimulant, and in the treatment of Alzheimer's disease and other central nervous system disorders. | acridines; aromatic amine | EC 3.1.1.7 (acetylcholinesterase) inhibitor |
nimodipine | nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm. Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure. | 2-methoxyethyl ester; C-nitro compound; dicarboxylic acids and O-substituted derivatives; diester; dihydropyridine; isopropyl ester | antihypertensive agent; calcium channel blocker; cardiovascular drug; vasodilator agent |
np 118809 | 1-(4-benzhydrylpiperazin-1-yl)-3,3-diphenylpropan-1-one: an N-type calcium channel blocker; structure in first source | ||
ith 4012 |